Rebecca Jasser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rebecca Jasser has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ari Waisman
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2 shared publications - Nishada S. Ramphal
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz
2 shared publications - Tommy Regen
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2 shared publications - Alma Nazlie Mohebiany
Institute for Molecular Medicine, Universitätsmedizin der Johannes-Gutenberg-Universität, Mainz, Germany
1 shared publication - Burkhard Becher
Institute of Experimental Immunology, University of Zurich, Switzerland
1 shared publication - Frederike Westermann
Institute of Experimental Immunology, University of Zurich 2 , Zurich
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2728329
Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging
1. The gut microbiota comprises a highly complex and dynamic community of microorganisms that profoundly influences physiological processes of the host. 1 Beyond its well-established roles in diges...
- 17 September 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2728329
Open AccessGut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging
1. The gut microbiota comprises a highly complex and dynamic community of microorganisms that profoundly influences physiological processes of the host. 1 Beyond its well-established roles in diges...
- 27 February 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (4)
NIK-driven IL-23 production by myeloid cells is a key factor in the development of autoimmune inflammation
NIK (Map3k14) is a central regulator of noncanonical NF-κB signaling and immune homeostasis. Mutations in this kinase are linked to autoimmune disorders, including multiple sclerosis (MS). Both germline and T cell–specific deletion of NIK had been demonstrated previously to be associated with resistance to developing experimental autoimmune encephalomyelitis (EAE), an animal model for MS. In this study, we show that NIK expression by circulating myeloid cells is crucial for EAE development. Mechanistically, we found starkly reduced priming of neuroantigen-specific T cells in the absence of NIK in CX3CR1+ cells. This reduction was associated with dysregulated expression of genes involved in antigen presentation and cell migration, as well as decreased IL-23 production. Notably, T cells primed by NIK-deficient myeloid cells regained their ability to induce EAE when incubated with IL-23 before being transferred into RagKO mice. Our data underline the crucial role of NIK in enabling myeloid cells to function effectively as antigen-presenting cells.
- 27 February 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (4)
NIK-driven IL-23 production by myeloid cells is a key factor in the development of autoimmune inflammation
NIK (Map3k14) is a central regulator of noncanonical NF-κB signaling and immune homeostasis. Mutations in this kinase are linked to autoimmune disorders, including multiple sclerosis (MS). Both germline and T cell–specific deletion of NIK had been demonstrated previously to be associated with resistance to developing experimental autoimmune encephalomyelitis (EAE), an animal model for MS. In this study, we show that NIK expression by circulating myeloid cells is crucial for EAE development. Mechanistically, we found starkly reduced priming of neuroantigen-specific T cells in the absence of NIK in CX3CR1+ cells. This reduction was associated with dysregulated expression of genes involved in antigen presentation and cell migration, as well as decreased IL-23 production. Notably, T cells primed by NIK-deficient myeloid cells regained their ability to induce EAE when incubated with IL-23 before being transferred into RagKO mice. Our data underline the crucial role of NIK in enabling myeloid cells to function effectively as antigen-presenting cells.